GDF15 and steatosis: Hence, the range wherein circulating GDF15 can exert steatosis-reducing actions and other metabolic benefits19 in adolescents may be much lower (0.8–1.2 ng/mL) than the range wherein it causes anorexia and weight loss9,18.